Overview
Next-generation sequencing (NGS) is an advanced form of DNA sequencing technology that can be used to rapidly sequence the entirety of a person's genome in a cost-efficient manner. NGS has become a powerful tool in the detection, diagnosis and management of cancer cases. It allows doctors to compare the genetic profile of a tumor to the patient's normal cells, thereby helping to identify genes that are mutated or amplified in cancer cells. In addition, NGS can be used to detect rare genetic variants that may not have been previously detected, which may be associated with cancer risk or treatment response. By utilizing NGS, healthcare providers are able to provide more targeted therapies and personalized treatments for cancer patients, which can ultimately improve patient care.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Current Immunoassays and Emerging Immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases
Allele Based Inference on Evolution and Extinction; A Genetic Drift Approach
How this research is being cited
The 3 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
2021 · medRxiv (Cold Spring Harbor Laboratory)
-
CFTR-mediated monocyte-macrophage dysfunction revealed by cystic fibrosis proband-parent comparisonsX. Zhang et al. · 2021 · medRxiv
A sample of recent works citing this journal's research on Next-generation Sequencing in Cancer, linking to each citing work.